RTTNews | Aug 3, 2021 08:17AM EDT

08:16 Tuesday, August 3, 2021 (RTTNews) - Ambrx Says First Patient Dosed In Phase 1 Trial For ARX517, ADC In Development To Treat PSMA Expressing Tumors

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved